Literature DB >> 11432513

Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed.

S Alfieri1, C Carriero, P Caprino, A Di Giorgio, A Sgadari, F Crucitti, G B Doglietto.   

Abstract

BACKGROUND: The number of hepatic resections for benign and malignant lesions has constantly increased over the past 20 years, as a consequence, surgical experience acquired over the past few years has decreased post-operative morbidity and mortality rates. AIMS: Analysing the relation between potential preoperative risk factors and the occurrence of severe post-operative complications, an attempt is made to identify the variables determining surgical risk in elective hepatic surgery both in normal and cirrhotic liver. PATIENTS AND METHODS: The hospital records of 254 patients who underwent elective liver surgical procedures for hepatic lesions in our department, between 1984 and 1999, were reviewed. The following variables were entered into univariate and multivariate analysis: age, sex, nature of liver lesion (benign or malignant), presence of cirrhosis or cholestasis, synchronous resection of other organs, disorders of blood coagulation, intraoperative blood requirement, the extent of surgical procedures and Pringle's manoeuvre. RESULTS AND
CONCLUSIONS: The multivariate analysis of the 254 surgical operations on the liver indicates that the most powerful independent predictors favouring a serious adverse effect includes intra-operative blood transfusions, advanced age and cirrhosis. Scrupulous preoperative clinical evaluation and expert surgical skills minimize intra-operative bleeding and proved to be the most significant factors influencing morbidity and mortality rates.

Entities:  

Mesh:

Year:  2001        PMID: 11432513     DOI: 10.1016/s1590-8658(01)80089-x

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  10 in total

1.  Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.

Authors:  Andrea Frilling; Gregor A Stavrou; Hans-Jörg Mischinger; Bernard de Hemptinne; Mogens Rokkjaer; Jürgen Klempnauer; Anders Thörne; Beat Gloor; Susanne Beckebaum; Mohamed F A Ghaffar; Christoph E Broelsch
Journal:  Langenbecks Arch Surg       Date:  2005-02-19       Impact factor: 3.445

Review 2.  Has laparoscopy increased surgical indications for benign tumors of the liver?

Authors:  Adriana Toro; Michel Gagner; Isidoro Di Carlo
Journal:  Langenbecks Arch Surg       Date:  2012-10-09       Impact factor: 3.445

Review 3.  A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.

Authors:  Chris D Mann; Tom Palser; Chris D Briggs; Iain Cameron; Myrrdin Rees; John Buckles; David P Berry
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

4.  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

5.  Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer.

Authors:  Gianlorenzo Dionigi; Luigi Boni; Francesca Rovera; Stefano Rausei; Salvatore Cuffari; Giovanni Cantone; Alessandro Bacuzzi; Renzo Dionigi
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

6.  Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.

Authors:  David A Kooby; Jennifer Stockman; Leah Ben-Porat; Mithat Gonen; William R Jarnagin; Ronald P Dematteo; Scott Tuorto; David Wuest; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

7.  Is close monitoring in the intensive care unit necessary after elective liver resection?

Authors:  Sung Hoon Kim; Jae Gil Lee; So Young Kwon; Jin Hong Lim; Won Oak Kim; Kyung Sik Kim
Journal:  J Korean Surg Soc       Date:  2012-08-27

8.  Comparison of TachoSil and TachoComb in patients undergoing liver resection-a randomized, double-blind, non-inferiority trial.

Authors:  S Kawasaki; H Origasa; V Tetens; M Kobayashi
Journal:  Langenbecks Arch Surg       Date:  2017-04-01       Impact factor: 3.445

9.  A multicenter, prospective, randomized clinical trial of marine mussel-inspired adhesive hemostatic materials, InnoSEAL Plus.

Authors:  Gyu-Seong Choi; Seoung Hoon Kim; Hyung Il Seo; Je Ho Ryu; Sung Pil Yun; Mi-Young Koh; Moon Sue Lee; Haeshin Lee; Jae Hun Kim
Journal:  Ann Surg Treat Res       Date:  2021-10-29       Impact factor: 1.859

10.  Serum arterial lactate concentration predicts mortality and organ dysfunction following liver resection.

Authors:  Matthew G Wiggans; Tim Starkie; Golnaz Shahtahmassebi; Tom Woolley; David Birt; Paul Erasmus; Ian Anderson; Matthew J Bowles; Somaiah Aroori; David A Stell
Journal:  Perioper Med (Lond)       Date:  2013-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.